2025-08-28 21:12:23
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
Mercury Laboratories Ltd Q4FY25 net profit at Rs. 1.11 crore
Posted On : 2025-05-14 17:37:06( TIMEZONE : IST )
Mercury Laboratories Ltd has reported Standalone financial results for the period ended March 31, 2025.
Financial Results (Q4 FY2025) - QoQ Comparison
The company has reported total income of Rs. 20.8436 crores during the period ended March 31, 2025 as compared to Rs. 20.1005 crores during the period ended December 31, 2024.
The company has posted net profit / (loss) of Rs. 1.1104 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs. 1.1928 crores for the period ended December 31, 2024.
The company has reported EPS of Rs. 9.25 for the period ended March 31, 2025 as compared to Rs. 9.94 for the period ended December 31, 2024.
| Financials | Q4 FY2025 | Q3 FY2025 | % Change |
| Total Income | ₹ 20.8436 crs | ₹20.1005 crs |  3.70% |
| Net Profit | ₹1.1104 crs | ₹1.1928 crs |  -6.91% |
| EPS | ₹9.25 | ₹9.94 | -6.94% |
Financial Results (Q4 FY2025) - YoY Comparison
The company has reported total income of Rs. 20.8436 crores during the period ended March 31, 2025 as compared to Rs.17.7781 crores during the period ended March 31, 2024.
The company has posted net profit / (loss) of Rs.1.1104 crores for the period ended March 31, 2025 as against net profit / (loss) of Rs.1.9103 crores for the period ended March 31, 2024.
The company has reported EPS of Rs.9.25 for the period ended March 31, 2025 as compared to Rs.15.92 for the period ended March 31, 2024.
| Financials | Q4 FY2025 | Q4 FY2024 | % Change |
| Total Income | ₹ 20.8436 crs | ₹17.7781 crs | 17.24% |
| Net Profit | ₹1.1104 crs | ₹1.9103 crs | -41.87% |
| EPS | ₹9.25 | ₹15.92 | -41.90% |
Financial Results (Year Ended FY2025) - YoY Comparison
The company has reported total income of Rs.76.1699 crores during the Financial Year ended March 31, 2025 as compared to Rs.76.6475 crores during the Financial Year ended March 31, 2024.
The company has posted net profit / (loss) of Rs.3.1449 crores for the Financial Year ended March 31, 2025 as against net profit / (loss) of Rs.5.6542 crores for the Financial Year ended March 31, 2024.
The company has reported EPS of Rs.26.21 for the Financial Year ended March 31, 2025 as compared to Rs.47.12 for the Financial Year ended March 31, 2024.
| Financials | Year Ended FY2025 | Year Ended FY2024 | % Change |
| Total Income | ₹76.1699 crs | ₹76.6475 crs | -0.62% |
| Net Profit | ₹3.1449 crs | ₹5.6542 crs | -44.38% |
| EPS | ₹26.21 | ₹47.12 | -44.38% |
Shares of Mercury Laboratories Ltd was last trading in BSE at Rs. 898.55 as compared to the previous close of Rs. 849.05. The total number of shares traded during the day was 10 in over 4 trades.
The stock hit an intraday high of Rs. 900.00 and intraday low of 897.00. The net turnover during the day was Rs. 8992.00.
